Brief: Theraclion announces first patients treated in U.S. Pivotal Multicentre FDA study

Theraclion SA

08/02/2017 07:01

Feb 8 (Reuters) - Theraclion SA  ALTHER.PA : 
    * Announces First Patients Treated In U.S. Pivotal 
Multicentre FDA Study  
 
Source text for Eikon:  ID:nBw8NjpS1a  
Further company coverage:  ALTHER.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))